452 related articles for article (PubMed ID: 22459073)
1. Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R⁻/⁻) mice.
Poti F; Costa S; Bergonzini V; Galletti M; Pignatti E; Weber C; Simoni M; Nofer JR
Vascul Pharmacol; 2012 Aug; 57(1):56-64. PubMed ID: 22459073
[TBL] [Abstract][Full Text] [Related]
2. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
Nofer JR; Bot M; Brodde M; Taylor PJ; Salm P; Brinkmann V; van Berkel T; Assmann G; Biessen EA
Circulation; 2007 Jan; 115(4):501-8. PubMed ID: 17242282
[TBL] [Abstract][Full Text] [Related]
3. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.
Potì F; Gualtieri F; Sacchi S; Weißen-Plenz G; Varga G; Brodde M; Weber C; Simoni M; Nofer JR
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1505-12. PubMed ID: 23640484
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine-1-phosphate agonists increase macrophage homing, lymphocyte contacts, and endothelial junctional complex formation in murine lymph nodes.
Singer II; Tian M; Wickham LA; Lin J; Matheravidathu SS; Forrest MJ; Mandala S; Quackenbush EJ
J Immunol; 2005 Dec; 175(11):7151-61. PubMed ID: 16301618
[TBL] [Abstract][Full Text] [Related]
5. Migration of CD4 T cells and dendritic cells toward sphingosine 1-phosphate (S1P) is mediated by different receptor subtypes: S1P regulates the functions of murine mature dendritic cells via S1P receptor type 3.
Maeda Y; Matsuyuki H; Shimano K; Kataoka H; Sugahara K; Chiba K
J Immunol; 2007 Mar; 178(6):3437-46. PubMed ID: 17339438
[TBL] [Abstract][Full Text] [Related]
6. The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity.
Sawicka E; Dubois G; Jarai G; Edwards M; Thomas M; Nicholls A; Albert R; Newson C; Brinkmann V; Walker C
J Immunol; 2005 Dec; 175(12):7973-80. PubMed ID: 16339533
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
Maeda Y; Seki N; Sato N; Sugahara K; Chiba K
Int Immunol; 2010 Jun; 22(6):515-25. PubMed ID: 20497959
[TBL] [Abstract][Full Text] [Related]
8. The sphingosine-1-phosphate receptor agonist FTY720 prevents the development of anti-glomerular basement membrane glomerulonephritis.
Sui M; Zhou J; Xie R; Liu X; Mu S; Jia X; Ma J; Wu H
Mol Biol Rep; 2012 Jan; 39(1):389-97. PubMed ID: 21833515
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis.
Keul P; Lucke S; von Wnuck Lipinski K; Bode C; Gräler M; Heusch G; Levkau B
Circ Res; 2011 Feb; 108(3):314-23. PubMed ID: 21164103
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine kinase inhibition exerts both pro- and anti-atherogenic effects in low-density lipoprotein receptor-deficient (LDL-R(-/-)) mice.
Poti F; Bot M; Costa S; Bergonzini V; Maines L; Varga G; Freise H; Robenek H; Simoni M; Nofer JR
Thromb Haemost; 2012 Mar; 107(3):552-61. PubMed ID: 22234485
[TBL] [Abstract][Full Text] [Related]
12. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
Chiba K
Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
[TBL] [Abstract][Full Text] [Related]
13. Cutting edge: Alternative signaling of Th17 cell development by sphingosine 1-phosphate.
Liao JJ; Huang MC; Goetzl EJ
J Immunol; 2007 May; 178(9):5425-8. PubMed ID: 17442922
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine-1-phosphate receptor agonism impairs the efficiency of the local immune response by altering trafficking of naive and antigen-activated CD4+ T cells.
Xie JH; Nomura N; Koprak SL; Quackenbush EJ; Forrest MJ; Rosen H
J Immunol; 2003 Apr; 170(7):3662-70. PubMed ID: 12646631
[TBL] [Abstract][Full Text] [Related]
15. Impaired initiation of contact hypersensitivity by FTY720.
Nakashima D; Kabashima K; Sakabe J; Sugita K; Kobayashi T; Yoshiki R; Tokura Y
J Invest Dermatol; 2008 Dec; 128(12):2833-41. PubMed ID: 18596826
[TBL] [Abstract][Full Text] [Related]
16. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs.
Hofmann M; Brinkmann V; Zerwes HG
Int Immunopharmacol; 2006 Dec; 6(13-14):1902-10. PubMed ID: 17161343
[TBL] [Abstract][Full Text] [Related]
17. IL-17-Producing Vγ4+ γδ T Cells Require Sphingosine 1-Phosphate Receptor 1 for Their Egress from the Lymph Nodes under Homeostatic and Inflammatory Conditions.
Maeda Y; Seki N; Kataoka H; Takemoto K; Utsumi H; Fukunari A; Sugahara K; Chiba K
J Immunol; 2015 Aug; 195(4):1408-16. PubMed ID: 26170380
[TBL] [Abstract][Full Text] [Related]
18. High density lipoprotein stimulated migration of macrophages depends on the scavenger receptor class B, type I, PDZK1 and Akt1 and is blocked by sphingosine 1 phosphate receptor antagonists.
Al-Jarallah A; Chen X; González L; Trigatti BL
PLoS One; 2014; 9(9):e106487. PubMed ID: 25188469
[TBL] [Abstract][Full Text] [Related]
19. Modulation of T cell homeostasis and alloreactivity under continuous FTY720 exposure.
Metzler B; Gfeller P; Wieczorek G; Li J; Nuesslein-Hildesheim B; Katopodis A; Mueller M; Brinkmann V
Int Immunol; 2008 May; 20(5):633-44. PubMed ID: 18343890
[TBL] [Abstract][Full Text] [Related]
20. Targeting S1P1 receptor protects against murine immunological hepatic injury through myeloid-derived suppressor cells.
Liu G; Bi Y; Wang R; Yang H; Zhang Y; Wang X; Liu H; Lu Y; Zhang Z; Chen W; Chu Y; Yang R
J Immunol; 2014 Apr; 192(7):3068-79. PubMed ID: 24567529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
